BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219 · see citing works

Differential expression analysis for sequence count data

Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581 · see citing works

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · see citing works

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911 · see citing works

Causal analysis approaches in Ingenuity Pathway Analysis

Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · see citing works

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works

Selective inhibition of BET bromodomains

Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · see citing works

Super-enhancers in the control of cell identity and disease

Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · see citing works

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · see citing works

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,820 · see citing works

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · see citing works

Phthalimide conjugation as a strategy for in vivo target protein degradation

Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760 · see citing works

Cardiac Fibrosis: The Fibroblast Awakens

Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596 · see citing works

Transcriptional Regulation and Its Misregulation in Disease

Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,588 · see citing works

Executive Summary: Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association

Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512 · see citing works

The Bromodomain Protein Brd4 Is a Positive Regulatory Component of P-TEFb and Stimulates RNA Polymerase II-Dependent Transcription

Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,301 · see citing works

Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4

Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,141 · see citing works

Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction

Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & D, E. B. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,101 · see citing works

Cardiac Plasticity

Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,089 · see citing works

Kruppel-Like Factor 15 Modulates Renal Interstitial Fibrosis by ERK/MAPK and JNK/MAPK Pathways Regulation

Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,036 · see citing works

Transforming growth factor (TGF)-β signaling in cardiac remodeling

Dobaczewski, M. P., Chen, W., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 933 · see citing works

Genetic lineage tracing defines myofibroblast origin and function in the injured heart

Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J. M., Maliken, B. D., Correll, R. N., Brody, M. J., Lin, S. J., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 896 · see citing works

The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition

Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 881 · see citing works

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

Sutton, M. S. J., Pfeffer, M. A., Plappert, T. A., Rouleau, J. L., Moyé, L. A., Dagenais, G. R., Lamas, G. A., Klein, M., Sussex, B. A., & Goldman, S. (1994) · Circulation · doi:10.1161/01.cir.89.1.68 · Cited by 821 · see citing works

Left Ventricular Remodeling in Heart Failure

Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 770 · see citing works

Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

Chapuy, B., McKeown, M. R., Lin, C. Y., Monti, S., Roemer, M. G. M., Qi, J., Rahl, P. B., Sun, H. H., Yeda, K. T., Doench, J. G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.003 · Cited by 735 · see citing works

Innate Immunity and the Failing Heart

Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 690 · see citing works

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature · doi:10.1038/nature16508 · Cited by 632 · see citing works

NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

Brown, J. D., Lin, C. Y., Duan, Q., Griffin, G., Federation, A. J., Paranal, R. M., Bair, S., Newton, G., Lichtman, A. H., Kung, A. L., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.024 · Cited by 614 · see citing works

Molecular basis of physiological heart growth: fundamental concepts and new players

Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536 · see citing works

Signaling effectors underlying pathologic growth and remodeling of the heart

van Berlo, J. H., Maillet, M., & Molkentin, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62839 · Cited by 446 · see citing works

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

Berthon, C., Raffoux, E., Thomas, X., Vey, N., Gomez‐Roca, C., Yee, K. W. L., Taussig, D. C., Rezaï, K., Roumier, C., Herait, P., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00247-1 · Cited by 423 · see citing works

Small-Molecule Inhibition of BRDT for Male Contraception

Matzuk, M. M., McKeown, M. R., Filippakopoulos, P., Li, Q., Ma, L., Agno, J. E., Lemieux, M. E., Picaud, S., Yu, R. N., Qi, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.045 · Cited by 421 · see citing works

C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling

Boström, P., Mann, N., Wu, J., Quintero, P. A., Plovie, E. R., Panáková, D., Gupta, R. K., Xiao, C., MacRae, C. A., Rosenzweig, A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.036 · Cited by 411 · see citing works

BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure

Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406 · see citing works

Targeting Epigenetic Readers in Cancer

Dawson, M. A., Kouzarides, T., & Huntly, B. J. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112635 · Cited by 400 · see citing works

miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling

Liu, X., Xiao, J., Zhu, H., Wei, X., Platt, C., Damilano, F., Xiao, C., Bezzerides, V. J., Boström, P., Che, L., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.014 · Cited by 392 · see citing works

Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription

Bisgrove, D. A., Mahmoudi, T., Henklein, P., & Verdin, E. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705053104 · Cited by 386 · see citing works

Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload

Koitabashi, N., Danner, T., Zaiman, A., Pinto, Y. M., Rowell, J., Mankowski, J. L., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44824 · Cited by 335 · see citing works

Toward transcriptional therapies for the failing heart: chemical screens to modulate genes

McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24144 · Cited by 288 · see citing works

Transcriptional Genomics Associates FOX Transcription Factors With Human Heart Failure

Hannenhalli, S. S., Putt, M., Gilmore, J. M., Wang, J., Parmacek, M. S., Epstein, J. A., Morrisey, E. E., Margulies, K. B., & Cappola, T. P. (2006) · Circulation · doi:10.1161/circulationaha.106.632430 · Cited by 257 · see citing works

Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy

Sano, M., Abdellatif, M., Oh, H., Xie, M., Bagella, L., Giordano, A., Michael, L. H., DeMayo, F. J., & Schneider, M. D. (2002) · Nature Medicine · doi:10.1038/nm778 · Cited by 236 · see citing works

BRD4 is a novel therapeutic target for liver fibrosis

Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211 · see citing works

Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition

Bolden, J. E., Tasdemir, N., Dow, L. E., van Es, J. H., Wilkinson, J. E., Zhao, Z., Clevers, H. C., & Lowe, S. W. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.025 · Cited by 188 · see citing works

Myocardial Infarction and Cardiac Remodelling in Mice

Yang, F., Liu, Y., Yang, X., Xu, J., Kapke, A., & Carretero, O. A. (2002) · Experimental Physiology · doi:10.1113/eph8702385 · Cited by 188 · see citing works

BET acetyl-lysine binding proteins control pathological cardiac hypertrophy

Spiltoir, J. I., Stratton, M. S., Cavasin, M. A., Demos-Davies, K., Reid, B. G., Qi, J., Bradner, J. E., & McKinsey, T. A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.017 · Cited by 174 · see citing works

Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes

Zhou, H., Dickson, M. E., Kim, M. S., Bassel‐Duby, R., & Olson, E. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516237112 · Cited by 170 · see citing works

Transcriptional Landscape of Cardiomyocyte Maturation

Uosaki, H., Cahan, P., Lee, D. I., Wang, S., Miyamoto, M., Fernandez, L., Kass, D. A., & Kwon, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.032 · Cited by 160 · see citing works

BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements

Bhagwat, A. S., Roe, J., Mok, B. Y., Hohmann, A. F., Shi, J., & Vakoc, C. R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.054 · Cited by 155 · see citing works

NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler

Shen, C., Ipsaro, J. J., Shi, J., Milazzo, J. P., Wang, E., Roe, J., Suzuki, Y., Pappin, D., Joshua‐Tor, L., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.033 · Cited by 154 · see citing works

Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs

Matkovich, S. J., Edwards, J. R., Grossenheider, T. C., Strong, C. D. G., & Dorn, G. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410622111 · Cited by 140 · see citing works

Cardio-Oncology

Bellinger, A. M., Arteaga, C. L., Force, T. L., Humphreys, B. D., Demetri, G. D., Druker, B. J., & Moslehi, J. J. (2015) · Circulation · doi:10.1161/circulationaha.115.010484 · Cited by 117 · see citing works

Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation

Haldar, S. M., Lu, Y., Jeyaraj, D., Kawanami, D., Cui, Y., Eapen, S. J., Hao, C., Li, Y., Doughman, Y., Watanabe, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000502 · Cited by 109 · see citing works

Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.

Jm, P., Ma, P., & D, E. B. M. (1987) · PubMed · Cited by 109 · see citing works

Phenotypic Screening with Human iPS Cell–Derived Cardiomyocytes: HTS-Compatible Assays for Interrogating Cardiac Hypertrophy

Carlson, C. B., Koonce, C. H., Aoyama, N., Einhorn, S., Fiene, S., Thompson, A., Swanson, B., Anson, B. D., & Kattman, S. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113500812 · Cited by 100 · see citing works

Deep RNA Sequencing Reveals Novel Cardiac Transcriptomic Signatures for Physiological and Pathological Hypertrophy

Song, H. K., Hong, S., Kim, T.-Y., & Kim, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035552 · Cited by 95 · see citing works

Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA

Stratton, M. S., Lin, C. Y., Anand, P., Tatman, P. D., Ferguson, B. S., Wickers, S. T., Ambardekar, A. V., Sucharov, C. C., Bradner, J. E., Haldar, S. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.074 · Cited by 84 · see citing works

Research Advances in Heart Failure

Braunwald, E. (2013) · Circulation Research · doi:10.1161/circresaha.113.302254 · Cited by 67 · see citing works

BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4/TRAF6/NF-κB pathway

SUN, Y., Huang, J., & Song, K. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2789 · Cited by 65 · see citing works

Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction

Unsöld, B. W., Kaul, A., Sbroggió, M., Schubert, C., Regitz‐Zagrosek, V., Brancaccio, M., Damilano, F., Hirsch, E., van Bilsen, M., Munts, C., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt235 · Cited by 52 · see citing works

BET-ting on chromatin-based therapeutics for heart failure

Haldar, S. M., & McKinsey, T. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.002 · Cited by 51 · see citing works

Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice

Lee, D. U., Katavolos, P., Palanisamy, G. S., Katewa, A., Sioson, C., Corpuz, J., Pang, J., DeMent, K., Choo, E. F., Ghilardi, N., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.013 · Cited by 47 · see citing works

Genetics and Disease of Ventricular MusclePreprint

Fatkin, D., Seidman, C. E., & Seidman, J. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021063 · Cited by 46 · see citing works

MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition

Xu, L., Yates, C., Lockyer, P., Xie, L., Bevilacqua, A., He, J., Lander, C., Patterson, C., & Willis, M. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.011 · Cited by 41 · see citing works

Epigenetic Mechanisms in Heart Failure Pathogenesis

Salvo, T. G. D., & Haldar, S. M. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001193 · Cited by 38 · see citing works

Roche bets on bromodomains

von Schaper, E. (2016) · Nature Biotechnology · doi:10.1038/nbt0416-361 · Cited by 12 · see citing works

Macrophage precursor cells from the left atrial appendage of the heart spontaneously reprogram into a C-kit+/CD45− stem cell-like phenotype

Leinonen, J., Emanuelov, A. K., Wolf, Y., Milgrom-Hoffman, M., Lichtstein, D., Hoss, S., Lotan, C., Tzahor, E., Jung, S., & Beeri, R. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.040 · Cited by 11 · see citing works

Role of the gut microbiota in nutrition and health

Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375 · see citing works

Microglia in Alzheimer’s disease

Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935 · see citing works

Cardiac fibrosis

Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229 · see citing works

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Gilan, O., Rioja, I., Knezevic, K., Bell, M. J., Yeung, M. M., Harker, N., Lam, E. Y. N., Chung, C., Bamborough, P., Petretich, M., et al. (2020) · Science · doi:10.1126/science.aaz8455 · Cited by 446 · see citing works

Bromodomains: a new target class for drug development

Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 438 · see citing works

Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity

Richards, D. J., Li, Y., Kerr, C. M., Yao, J., Beeson, G. C., Coyle, R. C., Chen, X., Jia, J., Damon, B., Wilson, R., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0539-4 · Cited by 439 · see citing works

Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials

Shi, Y., Zhang, H., Huang, S., Yin, L., Wang, F., Luo, P., & Huang, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01055-2 · Cited by 366 · see citing works

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Liu, M., Abad, B. L. D. J., & Cheng, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.021 · Cited by 353 · see citing works

The BET family in immunity and disease

Wang, N., Wu, R., Tang, D., & Kang, R. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00384-4 · Cited by 295 · see citing works

Targeting Age-Related Pathways in Heart Failure

Li, H., Hastings, M. H., Rhee, J., Trager, L. E., Roh, J. D., & Rosenzweig, A. (2020) · Circulation Research · doi:10.1161/circresaha.119.315889 · Cited by 270 · see citing works

A transcriptional switch governs fibroblast activation in heart disease

Alexanian, M., Przytycki, P. F., Micheletti, R., Padmanabhan, A., Ye, L., Travers, J. G., Gonzalez-Teran, B., Silva, A. C., Duan, Q., Ranade, S. S., et al. (2021) · Nature · doi:10.1038/s41586-021-03674-1 · Cited by 238 · see citing works

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection

Mills, R. J., Humphrey, S. J., Fortuna, P. R. J., Lor, M., Foster, S. R., Quaife-Ryan, G. A., Johnston, R. L., Dumenil, T. D., Bishop, C., Rudraraju, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.026 · Cited by 223 · see citing works

Oligogenic inheritance of a human heart disease involving a genetic modifier

Gifford, C. A., Ranade, S. S., Samarakoon, R., Salunga, H. T., de Soysa, Y., Huang, Y., Zhou, P., Elfenbein, A., Wyman, S. K., Bui, Y. K., et al. (2019) · Science · doi:10.1126/science.aat5056 · Cited by 216 · see citing works

DoubletDecon: Deconvoluting Doublets from Single-Cell RNA-Sequencing Data

DePasquale, E. A. K., Schnell, D. J., Van Camp, P.-J., Valiente-Alandí, Í., Blaxall, B. C., Grimes, H. L., Singh, H., & Salomonis, N. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.082 · Cited by 207 · see citing works

Cardiac fibrosis: potential therapeutic targets

Park, S., Nguyen, N. B., Pezhouman, A., & Ardehali, R. (2019) · Translational research · doi:10.1016/j.trsl.2019.03.001 · Cited by 194 · see citing works

Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation

Stratton, M. S., Bagchi, R. A., Felisbino, M. B., Hirsch, R. A., Smith, H. E., Riching, A. S., Enyart, B. Y., Koch, K. A., Cavasin, M. A., Alexanian, M., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315125 · Cited by 179 · see citing works

Therapeutic targets for cardiac fibrosis: from old school to next-gen

Travers, J. G., Tharp, C. A., Rubino, M., & McKinsey, T. A. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148554 · Cited by 176 · see citing works

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension

van der Feen, D. E., Kurakula, K., Tremblay, È., Boucherat, O., Bossers, G. P. L., Szulcek, R., Bourgeois, A., Lampron, M.-C., Habbout, K., Martineau, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2275oc · Cited by 157 · see citing works

BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs

Borck, P. C., Guo, L., & Plutzky, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.315929 · Cited by 157 · see citing works

Epigenetics in Cardiac Hypertrophy and Heart Failure

Liu, C., & Tang, W. H. W. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.05.011 · Cited by 150 · see citing works

Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axis

Li, X., Zhu, R., Jiang, H., Yin, Q., Gu, J., Chen, J., Ji, X., Wu, X., Fu, H., Wang, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.014 · Cited by 140 · see citing works

Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

Ravassa, S., López, B., Treibel, T. A., José, G. S., Losada-Fuentenebro, B., Tapia, L., Bayés‐Genís, A., Dı́ez, J., & González, A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101194 · Cited by 134 · see citing works

Chromatin remodelling drives immune cell–fibroblast communication in heart failure

Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Pelonero, A., Lee, C. Y., Sadagopan, N., Huang, Y., Auclair, K., et al. (2024) · Nature · doi:10.1038/s41586-024-08085-6 · Cited by 140 · see citing works

BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses

Dey, A., Yang, W., Gégonne, A., Nishiyama, A., Pan, R., Yagi, R., Grinberg, A., Finkelman, F. D., Pfeifer, K. E., Zhu, J., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100293 · Cited by 125 · see citing works

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

Zhang, Q.-J., Tran, T. A. T., Wang, M., Ranek, M. J., Kokkonen-Simon, K. M., Gao, J., Luo, X., Tan, W. H., Kyrychenko, V., Liao, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07173-2 · Cited by 123 · see citing works

Epigenetics in Cardiac Fibrosis

Felisbino, M. B., & McKinsey, T. A. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.05.003 · Cited by 120 · see citing works

Single-cell transcriptomics for the assessment of cardiac disease

Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117 · see citing works

Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy

Chelladurai, P., Boucherat, O., Stenmark, K. R., Kracht, M., Seeger, W., Bauer, U., Bonnet, S., & Pullamsetti, S. S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14932 · Cited by 116 · see citing works

Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out

Zent, J. M., & Guo, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493217 · Cited by 115 · see citing works

Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors

Bechter, O. E., & Schöffski, P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107479 · Cited by 113 · see citing works

Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases

Kulikowski, E., Rakai, B. D., & Wong, N. C. W. (2020) · Medicinal Research Reviews · doi:10.1002/med.21730 · Cited by 105 · see citing works

Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation

Liu, Z., Chen, H., Wang, P., Li, Y., Wold, E. A., Leonard, P. G., Joseph, S., Brasier, A. R., Tian, B., & Zhou, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00035 · Cited by 106 · see citing works

Systemic Aging Fuels Heart Failure: Molecular Mechanisms and Therapeutic Avenues

Fang, Z., Raza, U., Song, J., Lu, J., Yao, S., Liu, X., Zhang, W., & Li, S. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14947 · Cited by 114 · see citing works

Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells

Das, S., Senapati, P., Chen, Z., Reddy, M. A., Ganguly, R., Lanting, L. L., Mandi, V., Bansal, A., Leung, A., Zhang, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01629-7 · Cited by 103 · see citing works

Role of the Epigenome in Heart Failure

Papait, R., Serio, S., & Condorelli, G. (2020) · Physiological Reviews · doi:10.1152/physrev.00037.2019 · Cited by 106 · see citing works

p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization

Peng, J., Li, J.-C., Huang, J., Xu, P., Huang, H.-M., Liu, Y.-J., Yu, L., Yang, Y.-X., Zhou, B., Jiang, H.-L., et al. (2019) · Theranostics · doi:10.7150/thno.30707 · Cited by 101 · see citing works

BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo

Mu, J., Zhang, D., Tian, Y., Xie, Z., & Zou, M. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.09.003 · Cited by 102 · see citing works

Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis

Song, S., Liu, L., Yu, Y., Zhang, R., Li, Y., Cao, W., Xiao, Y., Fang, G., Li, Z., Wang, X., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.12.002 · Cited by 100 · see citing works

Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases

Morgado‐Pascual, J. L., Rayego‐Mateos, S., Tejedor-Santamaria, L., Suárez-Álvarez, B., & Ruiz‐Ortega, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01315 · Cited by 97 · see citing works

Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function

Kim, S. Y., Zhang, X., Schiattarella, G. G., Altamirano, F. J., Ramos, T. A. R., French, K. M., Jiang, N., Szweda, P. A., Evers, B. M., May, H. I., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047239 · Cited by 89 · see citing works

Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

the BETonMACE Investigators, Nicholls, S. J., Schwartz, G. G., Buhr, K. A., Ginsberg, H. N., Johansson, J. O., Kalantar‐Zadeh, K., Kulikowski, E., Toth, P. P., Wong, N. C. W., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01199-x · Cited by 88 · see citing works

Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779

Lin, H., Zhu, Y., Zheng, C., Hu, D., Ma, S., Chen, L., Wang, Q., Chen, Z., Xie, J., Yan, Y., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047000 · Cited by 88 · see citing works

DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure

Pepin, M. E., Drakos, S. G., Ha, C., Tristani‐Firouzi, M., Selzman, C. H., Fang, J. C., Wende, A. R., & Wever‐Pinzon, O. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00016.2019 · Cited by 87 · see citing works

BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice

Auguste, G., Rouhi, L., Matkovich, S. J., Coarfa, C., Robertson, M. J., Czernuszewicz, G., Gurha, P., & Marian, A. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135922 · Cited by 77 · see citing works

Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development

McKinsey, T. A., Foo, R., Anene-Nzelu, C. G., Travers, J. G., Vagnozzi, R. J., Weber, N., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac142 · Cited by 78 · see citing works

Epigenomes in Cardiovascular Disease

Rosa‐Garrido, M., Chapski, D. J., & Vondriska, T. M. (2018) · Circulation Research · doi:10.1161/circresaha.118.311597 · Cited by 71 · see citing works

Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site

Liu, Z., Li, Y., Chen, H., Lai, H., Wang, P., Wu, S., Wold, E. A., Leonard, P. G., Joseph, S., Hu, H., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01851 · Cited by 70 · see citing works

Platelet and Erythrocyte Membranes Coassembled Biomimetic Nanoparticles for Heart Failure Treatment

Li, Y., Yu, J., Chen, C., Chen, W., Lin, R., Wang, Y., Cui, W., Meng, J., Du, J., & Wang, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c04814 · Cited by 69 · see citing works

BRD4 inhibition regulates MAPK, NF‐κB signals, and autophagy to suppress MMP‐13 expression in diabetic intervertebral disc degeneration

Wang, J., Hu, J., Chen, X., Huang, C., Lin, J., Shao, Z., Gu, M., Wu, Y., Tian, N., Gao, W., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900703r · Cited by 68 · see citing works

Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins

Chen, D., Lu, T., Yan, Z., Lu, W., Zhou, F., Lyu, X., Xu, B., Jiang, H., Chen, K., Luo, C., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111633 · Cited by 68 · see citing works

cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes

DePasquale, E. A. K., Schnell, D., Dexheimer, P., Ferchen, K., Hay, S., Chetal, K., Valiente-Alandí, Í., Blaxall, B. C., Grimes, H. L., & Salomonis, N. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz789 · Cited by 67 · see citing works

Dual‐target inhibitors of bromodomain and extra‐terminal proteins in cancer: A review from medicinal chemistry perspectives

Feng, L., Wang, G., Chen, Y., He, G., Liu, B., Liu, J., Chiang, C., & Ouyang, L. (2022) · Medicinal Research Reviews · doi:10.1002/med.21859 · Cited by 65 · see citing works

Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances

Ahmed, S. T., Cerosaletti, K. M., James, E. A., Long, S. A., Mannering, S. I., Speake, C., Nakayama, M., Tree, T. I. M., Roep, B. O., Herold, K. C., et al. (2019) · Diabetes · doi:10.2337/db19-0119 · Cited by 64 · see citing works

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy

Knight, W. E., Cao, Y., Lin, Y.-H., Chi, C., Bai, B., Sparagna, G. C., Zhao, Y., Du, Y., Londono, P., Reisz, J. A., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.01.018 · Cited by 63 · see citing works

BRD4 (Bromodomain-Containing Protein 4) Interacts with GATA4 (GATA Binding Protein 4) to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes

Padmanabhan, A., Alexanian, M., Linares-Saldana, R., González-Terán, B., Andreoletti, G., Huang, Y., Connolly, A. J., Kim, W., Hsu, A., Duan, Q., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047753 · Cited by 60 · see citing works

BRD4 inhibition for the treatment of pathological organ fibrosis

Stratton, M. S., Haldar, S. M., & McKinsey, T. A. (2017) · F1000Research · doi:10.12688/f1000research.11339.1 · Cited by 58 · see citing works

Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases

Klein, K. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000744 · Cited by 58 · see citing works

Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases

Yu, Y., Su, X., Qin, Q., Hou, Y., Zhang, X., Zhang, H., Jia, M., & Chen, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105009 · Cited by 59 · see citing works

Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies

Hamdani, N., Costantino, S., Mügge, A., Lebeche, D., Tschöpe, C., Thum, T., & Paneni, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab197 · Cited by 56 · see citing works

Epigenetics-based therapeutics for myocardial fibrosis

Li, X., Yang, Y., Chen, S., Zhou, J., Li, J., & Cheng, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119186 · Cited by 55 · see citing works

Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling

Hsu, A., Duan, Q., McMahon, S., Huang, Y., Wood, S. A. B., Gray, N. S., Wang, B., Bruneau, B. G., & Haldar, S. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133753 · Cited by 54 · see citing works

Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact

Lunde, I. G., Rypdal, K. B., Linthout, S. V., Dı́ez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 54 · see citing works

Conserved Epigenetic Regulatory Logic Infers Genes Governing Cell Identity

Shim, W. J., Sinniah, E., Xu, J., Vitrinel, B., Alexanian, M., Andreoletti, G., Shen, S., Sun, Y., Balderson, B., Boix, C. A., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.11.001 · Cited by 50 · see citing works

Elevated H3K27ac in aged skeletal muscle leads to increase in extracellular matrix and fibrogenic conversion of muscle satellite cells

Zhou, J., So, K. K. H., Li, Y., Li, Y., Yuan, J., Ding, Y., Chen, F., Huang, Y., Liu, J., Lee, W., et al. (2019) · Aging Cell · doi:10.1111/acel.12996 · Cited by 51 · see citing works

Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction

Pinilla-Vera, M., Hahn, V. S., & Kass, D. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313682 · Cited by 49 · see citing works

Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling

Brasier, A. R., & Zhou, J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.002 · Cited by 48 · see citing works

TEA domain transcription factor 1 (TEAD1) induces cardiac fibroblasts cells remodeling through BRD4/Wnt4 pathway

Song, S., Zhang, X., Huang, Z., Zhao, Y., Lu, S., Zeng, L., Cai, F., Wang, T., Pei, Z., Weng, X., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01732-w · Cited by 47 · see citing works

Epigenetics and vascular diseases

Stratton, M. S., Farina, F. M., & Elia, L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.010 · Cited by 47 · see citing works

Relationship of state educational criteria and demographic variables to school-system prevalence of mental retardation.

Patrick, J. L., & Reschly, D. J. (1982) · PubMed · Cited by 47 · see citing works

The heterocellular heart: identities, interactions, and implications for cardiology

Lother, A., & Kohl, P. K. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01000-6 · Cited by 43 · see citing works

Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases

Li, Y., Chen, J., Bolinger, A. A., Chen, H., Liu, Z., Cong, Y., Brasier, A. R., Pinchuk, I. V., Tian, B., & Zhou, J. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab190 · Cited by 45 · see citing works

Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment

Gorica, E., Geiger, M. A., Venanzio, L. D., Atzemian, N., Kleeberger, J., Grigorian, D., Mongelli, A., Veseli, B. E., Mohammed, S. A., Ruschitzka, F. T., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02774-w · Cited by 42 · see citing works

The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy

Li, Z., Guo, Z., Lan, R., Cai, S., Lin, Z., Li, J., Wang, J., Li, Z., & Liu, P. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.012 · Cited by 42 · see citing works

BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy

Antolic, A., Wakimoto, H., Jiao, Z., Gorham, J. M., DePalma, S. R., Lemieux, M. E., Conner, D. A., Lee, D. Y., Qi, J., Seidman, J. G., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138687 · Cited by 41 · see citing works

Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis

Shao, J., Liu, J., & Zuo, S. (2022) · Cells · doi:10.3390/cells11152347 · Cited by 40 · see citing works

Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR‐Dependent FAK/AKT Signaling Activation

Zheng, X., Liu, L., Liu, J., Zhang, C., Zhang, J., Qi, Y., Xie, L., Zhang, C., Yao, G., & Bu, P. (2023) · Advanced Science · doi:10.1002/advs.202207631 · Cited by 40 · see citing works

Mechanisms of Myocardial Reverse Remodelling and Its Clinical Significance: A Scientific Statement of the ESC Working Group on Myocardial Function

Falcão‐Pires, I., Ferreira, A. F., Trindade, F., Bertrand, L., Ciccarelli, M., Visco, V., Dawson, D. K., Hamdani, N., Laake, L. W. V., Lezoualc’h, F., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3264 · Cited by 43 · see citing works

The Long Noncoding RNA Hotair Regulates Oxidative Stress and Cardiac Myocyte Apoptosis during Ischemia-Reperfusion Injury

Meng, K., Jiao, J., Zhu, R., Wang, B.-Y., Mao, X., Zhong, Y., Zhu, Z., Yu, K., Ding, Y. P., Xu, W., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1645249 · Cited by 40 · see citing works

The therapeutic potential of BRD4 in cardiovascular disease

Lin, S., & Du, L. (2020) · Hypertension Research · doi:10.1038/s41440-020-0459-4 · Cited by 40 · see citing works

BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring

Qu, M., Zhang, X., Hu, X., Dong, M., Pan, X., Bian, J., & Zhou, Q. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0066-1 · Cited by 39 · see citing works

Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis

He, Z., Jiao, H., An, Q., Zhang, X., Dan, Z., Xu, J., Liu, H., Ma, L., & Zhao, W. H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.018 · Cited by 40 · see citing works

Epi-Drugs in Heart Failure

Gorica, E., Mohammed, S. A., Ambrosini, S., Calderone, V., Costantino, S., & Paneni, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923014 · Cited by 39 · see citing works

Estrogen signaling as a bridge between the nucleus and mitochondria in cardiovascular diseases

Guajardo-Correa, E., Silva-Agüero, J. F., Calle, X., Chiong, M., Henríquez, M., García‐Rivas, G., Latorre, M., & Parra, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.968373 · Cited by 38 · see citing works

Inhibition of BRD 4 attenuates cardiomyocyte apoptosis via NF ‐κB pathway in a rat model of myocardial infarction

Sun, Y., Xie, Y., Du, L., Sun, J., & Liu, Z. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12320 · Cited by 37 · see citing works

Structure-Based Discovery and Optimization of Furo[3,2- c ]pyridin-4(5 H )-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors

Li, J., Zhang, C., Xu, H., Wang, C., Dong, R., Shen, H., Zhuang, X., Chen, X., Li, Q., Lu, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00100 · Cited by 36 · see citing works

The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy

Dabravolski, S. A., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Sukhorukov, V. N., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147863 · Cited by 35 · see citing works

Unlocking the secrets of aging: Epigenetic reader BRD4 as the target to combatting aging-related diseases

Sun, J., Gui, Y., Zhou, S., & Zheng, X. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.11.006 · Cited by 32 · see citing works

BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity

Khoueiry, P., Gahlawat, A. W., Petretich, M., Michon, A., Simola, D. F., Lam, E. Y. N., Furlong, E. E. M., Beneš, V., Dawson, M. A., Prinjha, R. K., et al. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0286-5 · Cited by 32 · see citing works

Transcription Factor GATA4 Regulates Cell Type–Specific Splicing Through Direct Interaction With RNA in Human Induced Pluripotent Stem Cell–Derived Cardiac Progenitors

Zhu, L., Choudhary, K., González‐Terán, B., Ang, Y.-S., Thomas, R., Stone, N. R., Liu, L., Zhou, P., Zhu, C., Ruan, H., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.057620 · Cited by 32 · see citing works

BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment

Andrieu, G. P., Shafran, J. S., Deeney, J. T., Bharadwaj, K. R., Rangarajan, A., & Denis, G. V. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ri0917-380rr · Cited by 32 · see citing works

Effective Modulation of Inflammation and Oxidative Stress for Enhanced Regeneration of Intervertebral Discs Using 3D Porous Hybrid Protein Nanoscaffold

Yang, L., Bhujel, B., Hou, Y., Luo, J., An, S. B., Han, I., & Lee, K. (2023) · Advanced Materials · doi:10.1002/adma.202303021 · Cited by 31 · see citing works

Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potential

Meddens, C., van der List, A. C. J., Nieuwenhuis, E. E. S., & Mokrý, M. (2019) · Gut · doi:10.1136/gutjnl-2018-317516 · Cited by 30 · see citing works

The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats

Piquereau, J., Boët, A., Péchoux, C., Antigny, F., Lambert, M., Gressette, M., Ranchoux, B., Gambaryan, N., Domergue, V., Mumby, S. E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071527 · Cited by 29 · see citing works

Progress in the development of domain selective inhibitors of the bromo and extra terminal domain family (BET) proteins

Fu, Y., Zhang, Y., & Sun, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113853 · Cited by 28 · see citing works

Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin

Burke, R. M., Dirkx, R. A., Quijada, P. J., Lighthouse, J. K., Mohan, A. M., O’Brien, M., Wojciechowski, W., Woeller, C. F., Phipps, R. P., Alexis, J. D., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317791 · Cited by 27 · see citing works

Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics

Ma, Z., Bolinger, A. A., Zhou, J., & Tian, B. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2175317 · Cited by 27 · see citing works

Etiology of super-enhancer reprogramming and activation in cancer

Zhou, R. W., & Parsons, R. E. (2023) · Epigenetics & Chromatin · doi:10.1186/s13072-023-00502-w · Cited by 30 · see citing works

Epigenetic therapies in heart failure

Alexanian, M., Padmanabhan, A., McKinsey, T. A., & Haldar, S. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.012 · Cited by 26 · see citing works

The Role of Cardiac Fibroblast Heterogeneity in Myocardial Fibrosis and Its Novel Therapeutic Potential

Chimenti, I., Pagano, F., Cozzolino, C., Icolaro, F., Floris, E., & Picchio, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125882 · Cited by 25 · see citing works

BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy

Guo, M., Wang, H., & Chen, W. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.05.018 · Cited by 25 · see citing works

BRD4 inhibition slows HF progression

Ummarino, D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.86 · Cited by 11 · see citing works

BET inhibitor attenuates heart failure

Cully, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.125 · Cited by 12 · see citing works

BET Protein-Mediated Transcriptional Regulation in Heart Failure

Ijaz, T., & Burke, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116059 · Cited by 14 · see citing works

BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy

Antolic, A., Wakimoto, H., Jiao, Z., Gorham, J. M., DePalma, S. R., Lemieux, M. E., Conner, D. A., Lee, D. Y., Qi, J., Seidman, J. G., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138687 · Cited by 41 · see citing works

From Chromatin Readers to Heart Failure: BET Protein Family Members in Cardiac Remodeling

Lbik, D. (2019) · doi:10.53846/goediss-7453 · Cited by 1 · see citing works